INGREZZA Sprinkle

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70370-4080
  • Package NDC 70370-4080-1
  • Application number NDA218390
  • SPL ID bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6b
  • SPL set ID 4c970164-cafb-421f-9eb5-c226ef0a3417
  • UNII 5SML1T733B
  • RxCUI 1918224
  • RxCUI 1918230
  • RxCUI 1986329
  • RxCUI 1986331
  • RxCUI 2054268
  • RxCUI 2054269
  • RxCUI 2541511
  • RxCUI 2541513
  • RxCUI 2665627
  • RxCUI 2665628
  • RxCUI 2680779
  • RxCUI 2680780
  • RxCUI 2680781
  • RxCUI 2680782
  • RxCUI 2680783
  • RxCUI 2680784

What the source publishes

Labeler
Neurocrine Biosciences, Inc.
Active ingredients
Valbenazine
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70370-4080_bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6b
{
  "name": "INGREZZA Sprinkle",
  "splId": "bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6b",
  "labels": [
    {
      "setId": "4c970164-cafb-421f-9eb5-c226ef0a3417",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c970164-cafb-421f-9eb5-c226ef0a3417",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c970164-cafb-421f-9eb5-c226ef0a3417"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Neurocrine Biosciences, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 CAPSULE in 1 BOTTLE (70370-4080-1)",
      "package_ndc": "70370-4080-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240430"
    }
  ],
  "productId": "70370-4080_bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6b",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "70370-4080",
  "deaSchedule": null,
  "genericName": "Valbenazine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "VALBENAZINE TOSYLATE",
      "strength": "80 mg/1"
    }
  ],
  "applicationNumber": "NDA218390",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240430",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0370370408011",
      "0370370404013",
      "0370370204019",
      "0370370108010",
      "0370370406017",
      "0370370106016"
    ],
    "unii": [
      "5SML1T733B"
    ],
    "rxcui": [
      "1918224",
      "1918230",
      "1986329",
      "1986331",
      "2054268",
      "2054269",
      "2541511",
      "2541513",
      "2665627",
      "2665628",
      "2680779",
      "2680780",
      "2680781",
      "2680782",
      "2680783",
      "2680784"
    ],
    "spl_set_id": [
      "4c970164-cafb-421f-9eb5-c226ef0a3417"
    ],
    "manufacturer_name": [
      "Neurocrine Biosciences, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70370-4080_bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6b"